Replimune Group
REPL
141 hedge funds and large institutions have $1.27B invested in Replimune Group in 2023 Q2 according to their latest regulatory filings, with 20 funds opening new positions, 45 increasing their positions, 59 reducing their positions, and 19 closing their positions.
34% more capital invested
Capital invested by funds: $949M → $1.27B (+$318M)
5% more first-time investments, than exits
New positions opened: 20 | Existing positions closed: 19
1% more funds holding
Funds holding: 140 → 141 (+1)
0% more funds holding in top 10
Funds holding in top 10: 4 → 4 (0)
0.48% less ownership
Funds ownership: 94.98% → 94.5% (-0.48%)
24% less repeat investments, than reductions
Existing positions increased: 45 | Existing positions reduced: 59
34% less call options, than puts
Call options by funds: $9.34M | Put options by funds: $14.2M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
+$20.3M |
| 2 |
RG
Redmile Group
San Francisco,
California
|
+$11.9M |
| 3 |
Marshall Wace
London,
United Kingdom
|
+$11.5M |
| 4 |
B
Braidwell
Stamford,
Connecticut
|
+$8.09M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
+$7.64M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
State Street
Boston,
Massachusetts
|
-$15.9M |
| 2 |
Victory Capital Management
San Antonio,
Texas
|
-$12.2M |
| 3 |
T. Rowe Price Investment Management
Baltimore,
Maryland
|
-$9.82M |
| 4 |
FLSM
Frazier Life Sciences Management
Palo Alto,
California
|
-$5.86M |
| 5 |
Morgan Stanley
New York
|
-$3.83M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
GCP
151
GSA Capital Partners
London,
United Kingdom
| – | -$418K | -23,642 | Closed |
|
|
HS
152
HighVista Strategies
Boston,
Massachusetts
| – | -$304K | -17,231 | Closed |
|
|
EFM
153
E Fund Management
Guangzhou,
China
| – | -$217K | -12,305 | Closed |
|
154
SG Americas Securities
New York
| – | -$212K | -12,003 | Closed |
|
|
FRM
155
Fox Run Management
Greenwich,
Connecticut
| – | -$191K | -10,832 | Closed |
|
|
SO
156
STRS Ohio
Columbus,
Ohio
| – | -$75K | -4,300 | Closed |
|
157
Robeco Institutional Asset Management
Rotterdam,
Netherlands
| – | -$62.7K | -3,552 | Closed |
|
|
TWA
158
TCI Wealth Advisors
Tucson,
Arizona
| – | -$4.06K | -230 | Closed |
|
REPL Hedge Fund Activity: Q2 2023 in Review
141 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in Replimune Group (REPL) for Q2 2023, worth a combined $1.27B — up 34% from $949M a quarter earlier.
Buyers outnumbered sellers: 20 funds opened new REPL positions and 19 closed out — a net gain of 1 holder — while 45 added to existing stakes and 59 trimmed.
The largest buyer was Lord, Abbett & Co, opening a new position worth an estimated $20.3M. The largest seller was State Street, cutting an estimated $15.9M.
- 141 institutional investors held Replimune Group (REPL) as of Q2 2023, up from 140 in Q1 2023.
- Funds reported $1.27B of Replimune Group stock for Q2 2023, up 34% quarter-over-quarter.
- 20 funds opened new Replimune Group positions in Q2 2023 and 19 closed out, a net change of +1 holder.
- The largest Replimune Group buyer in Q2 2023 was Lord, Abbett & Co, an estimated $20.3M added.
- The largest Replimune Group seller in Q2 2023 was State Street, an estimated $15.9M sold.
Based on aggregated 13F filings for Q2 2023.